Skip to main content

Table 3 Baseline, 6-week, 4- and 12-month follow-up HOOS, OHS and EQ-5D scores

From: Does functional planning, 3D templating and patient-specific instrumentation improve accuracy in total hip replacement?— a randomized controlled trial

Outcome

Time point

Standard (n=27)

OPS (n=27)

All (n=54)

Hip disability and osteoarthritis outcome score (HOOS)

HOOS: Pain

Baseline

34.8 (14.1)

33.0 (14.0)

33.9 (13.9)

6 weeks

79.8 (22.5)

83.7 (14.0)

81.8 (18.6)

4 months

87.9 (18.0)

90.2 (12.0)

89.1 (15.1)

12 Months

89.9 (18.4)

91.8 (15.3)

90.9 (16.8)

HOOS: Symptoms

Baseline

39.4 (18.9)

34.3 (15.1)

36.9 (17.1)

6 weeks

77.4 (18.4)

80.8 (11.7)

79.1 (15.3)

4 months

82.7 (16.9)

84.6 (11.9)

83.7 (14.5)

12 Months

88.6 (16.4)

86.2 (16.8)

87.4 (16.5)

HOOS: ADL

Baseline

37.8 (19.0)

34.9 (18.1)

36.3 (18.4)

6 weeks

74.1 (21.8)

79.5 (12.1)

76.8 (17.6)

4 months

83.9 (18.1)

87.2 (14.2)

85.6 (16.1)

12 Months

90.4 (18.8)

90.5 (17.7)

90.5 (18.1)

HOOS: Sport/recreation

Baseline

18.5 (20.8)

14.4 (15.9)

16.4 (18.5)

6 weeks

47.5 (24.1)

58.4 (21.0)

53.1 (23.0)

4 months

71.9 (27.1)

72.8 (24.7)

72.3 (25.6)

12 Months

82.2 (25.2)

82.0 (24.5)

82.1 (24.6)

HOOS: QoL

Baseline

24.8 (16.9)

19.9 (15.1)

22.3 (16.1)

6 weeks

55.2 (26.3)

57.7 (16.5)

56.5 (21.7)

4 months

76.0 (21.8)

76.5 (24.5)

76.3 (23.0)

12 Months

82.8 (20.7)

82.0 (20.0)

82.4 (20.2)

Oxford Hip Score

OHS

Baseline

16.3 (6.3)

17.9 (7.9)

17.1 (7.1)

6 weeks

30.9 (10.9)

35.7 (6.6)

33.4 (9.2)

4 months

40.1 (9.3)

41.0 (7.3)

40.6 (8.3)

12 Months

42.4 (9.8)

43.1 (7.3)

42.8 (8.5)

EQ-5D

EQ-5D

Baseline

0.428 (0.235)

0.420 (0.261)

0.424 (0.246)

6 weeks

0.691 (0.243)

0.748 (0.148)

0.720 (0.200)

4 months

0.802 (0.201)

0.744 (0.289)

0.772 (0.249)

12 Months

0.823 (0.180)

0.753 (0.232)

0.787 (0.209)